SeekingAlpha · Mar 10, 2026
Nuwellis, Inc. (NUWE) Q4 2025 Earnings Call Transcript
Nuwellis, Inc. (NUWE) Q4 2025 Earnings Call March 10, 2026 9:00 AM EDTCompany ParticipantsLeah McMullen - Director of CommunicationsJohn Erb - CEO,...
NU
NASDAQ · NUWE
Nuwellis, Inc.
Healthcare · Medical - Devices
$0.82
Up+$0.28 (+33.74%)
Updated Sep 17, 2026, 10:42 PM
SID Score
2.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.25M
- P/E ratio
- -0.03
- Dividend yield
- 0.00%
- 52-week range
- $0.71 – $172.90
- Volume
- 283.96K
- Avg. volume
- 166.14K
Price performance
NUWE price history
1M range · 20 trading sessions · Daily adjusted prices
NUWE closed at $0.82 after 20 trading sessions, down 30.34% for the selected period.
- Last close
- $0.82
- Period change
- -30.34%
- Period low
- $0.73
- Period high
- $1.17
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $0.8055 | $0.8629 | $0.80 | $0.815 | 283.96K |
| Sep 15, 2026 | $0.82 | $0.888 | $0.80 | $0.8449 | 644.61K |
| Sep 14, 2026 | $0.777 | $0.8065 | $0.7738 | $0.7964 | 114.18K |
| Sep 11, 2026 | $0.76 | $0.8087 | $0.76 | $0.774 | 141.46K |
| Sep 10, 2026 | $0.7985 | $0.8055 | $0.768 | $0.7683 | 208.59K |
| Sep 9, 2026 | $0.7901 | $0.8097 | $0.765 | $0.7998 | 131.68K |
| Sep 8, 2026 | $0.81 | $0.829 | $0.7711 | $0.7878 | 305.77K |
| Sep 4, 2026 | $0.75 | $0.7823 | $0.7422 | $0.7809 | 223.49K |
| Sep 3, 2026 | $0.7512 | $0.81 | $0.7112 | $0.7347 | 343.74K |
| Sep 2, 2026 | $0.7417 | $0.7712 | $0.7218 | $0.739 | 224.84K |
| Sep 1, 2026 | $0.76 | $0.7899 | $0.7553 | $0.7572 | 291.11K |
| Aug 31, 2026 | $0.88 | $0.883 | $0.7551 | $0.7925 | 758.03K |
| Aug 28, 2026 | $1.00 | $1.0499 | $0.865 | $0.8889 | 1.36M |
| Aug 27, 2026 | $0.99 | $1.03 | $0.97 | $0.989 | 980.7K |
| Aug 26, 2026 | $1.045 | $1.11 | $0.98 | $1.01 | 24.39M |
| Aug 25, 2026 | $1.06 | $1.06 | $0.935 | $0.9592 | 673.31K |
| Aug 24, 2026 | $1.18 | $1.19 | $1.05 | $1.05 | 420.72K |
| Aug 21, 2026 | $1.11 | $1.18 | $1.11 | $1.16 | 226.05K |
| Aug 20, 2026 | $1.17 | $1.1851 | $1.12 | $1.12 | 226.91K |
| Aug 19, 2026 | $1.17 | $1.2999 | $1.14 | $1.17 | 604.7K |
Latest NUWE news
The latest Smart Investors Daily articles mentioning NUWE.
Stock researchCompany · Overview
NUWE research
Overview
Company profile and research snapshot.
Company profile
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 13, 2024 | Roth MKM | Buy | — |
| Jul 29, 2024 | Roth MKM | Buy | — |
| Nov 8, 2023 | Ladenburg Thalmann | Neutral | — |
News briefing
No generated briefing is available yet.
ChartMill · Mar 10, 2026
Nuwellis Inc (NASDAQ:NUWE) Stock Surges 10% on Q4 Earnings Beat
Nuwellis stock surges after Q4 earnings beat estimates, with revenue and EPS exceeding analyst expectations.
Benzinga · Mar 10, 2026
Nuwellis Q4 EPS $(1.50) Beats $(1.56) Estimate, Sales $2.424M Beat $2.310M Estimate
Nuwellis (NASDAQ:NUWE) reported quarterly losses of $(1.50) per share which beat the analyst consensus estimate of $(1.56) by 3.85 percent. This is a 91.8 percent increase over losses of $(18.30) per share from the same
Benzinga · Mar 9, 2026
Nuwellis Earnings Preview
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
